The Siminovitch Prize is Canada's largest theatre award recognizing excellence in mid-career directors, playwrights and designers. $ 100,000 is awarded annually to recipients.
8-570: Anyone may nominate a qualified candidate for the Prize, and winners are selected by a jury made up of prominent theatre professionals. Nominees must be a professional director, playwright, or designer who, in the preceding 10 years, has made a significant creative contribution to no fewer than three noteworthy theatre projects in Canada. A condition of the award is that one quarter of the prize (CAD$ 25,000) must be awarded to an emerging artist "Protégé" selected by
16-627: The University of Toronto , then called Department of Medical Cell Biology. He was the author or coauthor, at last count, of over 147 scientific papers, reviews, and articles in journals and books. He married Elinore, a playwright who died in 1995. They had three daughters. The annual Elinore & Lou Siminovitch Prize in Theatre is named in his and his wife's honour. Siminovitch died in April 2021 in Ontario at
24-651: The 12th edition of the prize would be its last. In an interview one of the prize's founders, Joseph Rotman, he stated that the Siminovitch Prize was never conceived to run in perpetuity. However, in July 2013, new financial supporters were secured resulting in the revival of the Siminovitch Prize. The Prize has continued ever since, under the direction of the Siminovitch Prize Foundation, funded annually by individual donors and corporate sponsors. The recipients of
32-525: The Siminovitch Prize since its inception are: The protégé recipients of the Siminovitch prize are: Louis Siminovitch Louis Siminovitch CC OOnt FRS FRSC (May 1, 1920 – April 6, 2021) was a Canadian molecular biologist . He was a pioneer in human genetics , researcher into the genetic basis of muscular dystrophy and cystic fibrosis , and helped establish Ontario programs exploring genetic roots of cancer. Siminovitch
40-500: The distinguished scientist Louis ("Lou") Siminovitch and his late wife Elinore Siminovitch who was a pioneering playwright. A group of Dr. Siminovitch’s friends and colleagues came together on the occasion of his 80th birthday to create this award . Twelve individuals and six organizations founded the prize; primary amongst them was the prize's largest financial sponsor, the BMO Financial Group . In March 2012, BMO announced that
48-520: The winner. The Protégé must be an individual involved in professional direction, playwriting, or design in Canadian theatre. The winner may choose to grant the amount to a single Protégé or divide it between two eligible Protégés. Three finalists also receive CAD$ 5,000. Formally, the Elinore & Lou Siminovitch Prize in Theatre, the Siminovitch Prize was launched in 2000 to honour the values and achievements of
56-580: Was Joyce Taylor-Papadimitriou . He helped establish the Department of Genetics at the Hospital for Sick Children as geneticist in chief, where he worked from 1970 to 1985. From 1983 to 1994 he was the founding director of research at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital (Toronto) . He was the founder and the first Chair of the Department of Molecular Genetics at
64-601: Was born in Montreal, Quebec , the son of Goldie and Nathan Siminovitch, who were Jewish emigrants from Eastern Europe. He won a scholarship in chemistry to McGill University , earning a doctorate in 1944. He then studied at the Pasteur Institute in Paris. In 1953 he joined Toronto 's Connaught Medical Research Laboratories . Later he joined the University of Toronto and worked there from 1956 to 1985. One of his doctoral students
#614385